Table 3.
Demographics for control and transplant patient groups used for urine and biopsy analyses
| Demographic | Control (n=174) | Transplant (n=251) |
|---|---|---|
| Age (yr) | 40±12 | 40±19 |
| Men | 58 (33) | 162 (64.5) |
| Race | ||
| Caucasian | 135 (77.6) | 189 (75.3) |
| African American | 18 (10.3) | 43 (17.1) |
| Asian | 12 (6.9) | 8 (3.2) |
| Other | 9 (5.2) | 11 (4.4) |
| UPCR | 0.04 (0.03–0.06) | 0.13 (0.07–0.38) |
| eGFR (ml/min per 1.73 m2) | NA | 51±20 |
| Transplant category | ||
| Deceased donor | 111 (44.2) | |
| Living related | 65 (25.9) | |
| Living unrelated | 75 (29.9) | |
| Years post-transplant | ||
| <1 | 130 (51.8) | |
| 1–2 | 30 (12.0) | |
| 2–5 | 40 (15.9) | |
| >5 | 51 (20.3) | |
| Cause of ESRD | ||
| Diabetic nephropathy | 65 (25.9) | |
| Hypertension | 38 (15.1) | |
| ADPKD | 25 (10.0) | |
| FSGS | 15 (6.0) | |
| Other glomerulopathies | 53 (21.1) | |
| Other | 55 (21.9) |
Dat are presented as n (%), mean±1 SD, or median (interquartile range). UPCR, urine protein/creatinine ratio; NA, not available.